Smith, I., Robertson, J., Kilburn, L., Wilcox, M., Evans, A., Holcombe, C., . . . Dowsett, M. (2020). Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): An open-label, multicentre, parallel-group, randomised, phase 3 trial. Lancet Oncol.
Citação norma ChicagoSmith, Ian, et al. "Long-term Outcome and Prognostic Value of Ki67 After Perioperative Endocrine Therapy in Postmenopausal Women With Hormone-sensitive Early Breast Cancer (POETIC): An Open-label, Multicentre, Parallel-group, Randomised, Phase 3 Trial." Lancet Oncol 2020.
ציטוט MLASmith, Ian, et al. "Long-term Outcome and Prognostic Value of Ki67 After Perioperative Endocrine Therapy in Postmenopausal Women With Hormone-sensitive Early Breast Cancer (POETIC): An Open-label, Multicentre, Parallel-group, Randomised, Phase 3 Trial." Lancet Oncol 2020.